Closed
SectorHealthcare
1.43 11.72
24h
Min
1.34
Max
1.46
Income | 206K -60M |
---|---|
EPS | -0.28 |
Profit margin | 272,450 |
Employees | 226 |
EBITDA | -302K -56M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +500.78% upside |
Next Earnings | 6 sie 2025 |
---|
Market Cap | 22M 278M |
---|---|
Previous open | -10.29 |
Previous close | 1.43 |
By Acuity
60%
40%
334 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 7.75 USD 500.78%
High 14 USD
Low 2.5 USD
Based on 13 Wall Street analysts offering 12 month price targets forAllogene Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$